Ginkgo Bioworks Holdings Inc

DNA

Company Profile

  • Business description

    Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

  • Contact

    27 Drydock Avenue
    8th Floor
    BostonMA02210
    USA

    T: +1 877 422-5362

    https://www.ginkgobioworks.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    834

Stocks News & Analysis

stocks

Alphabet earnings: Continued momentum on cloud and search as capital expenses set to mount

Strong fourth quarter earnings.
stocks

Eli Lilly earnings: Revenue increases reflect global demand for oral obesity therapies

We’ve raised our fair value estimate of Lilly stock.
stocks

ASX listed software provider joins global sell-off

Our thesis remains unchanged.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,154.9049.70-0.54%
CAC 408,238.1723.99-0.29%
DAX 4024,491.06111.98-0.46%
Dow JONES (US)49,176.7864.21-0.13%
FTSE 10010,309.2293.12-0.90%
HKSE26,885.2437.920.14%
NASDAQ22,726.85528.34-2.27%
Nikkei 22553,818.04475.32-0.88%
NZX 50 Index13,444.0223.27-0.17%
S&P 5006,835.8546.87-0.68%
S&P/ASX 2008,889.2038.60-0.43%
SSE Composite Index4,075.9226.29-0.64%

Market Movers